The complaint alleges that PROCEPT executives systematically pulled sales forward from future periods, creating an artificial surplus of inventory that distorted the company's financial health. These actions reportedly led to materially misleading public statements throughout the two-year class period. Investors seeking to recover losses must move before the September 22, 2026, deadline.
In section Releases
Investors File Class Action Lawsuit Against PROCEPT BioRobotics
Shareholders who purchased PROCEPT BioRobotics stock between February 28, 2024, and February 25, 2026, are now eligible to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, claiming the company misled the market by inflating revenue through aggressive, unsustainable discounting practices.
The DJS Law Group, led by David J. Schwartz, is representing the potential class. Shareholders do not need to be appointed as a lead plaintiff to participate in a eventual recovery, though the firm is currently organizing the litigation. The case focuses on sections 10(b) and 20(a) of the Securities Exchange Act of 1934, alongside SEC Rule 10b-5, which governs the dissemination of false information to the public markets.
Comments (0)
No comments yet. Be the first!